Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$241K Buy
+3,579
New +$238K 0.04% 100
2020
Q4
Sell
-112,236
Closed -$11.6M 93
2020
Q3
$11.6M Buy
112,236
+4,616
+4% +$482K 4.18% 6
2020
Q2
$10.9M Buy
107,620
+22,652
+27% +$2.03M 4.47% 5
2020
Q1
$7.12M Buy
84,968
+40,064
+89% +$2.49M 3.27% 14
2019
Q4
$2.46M Buy
44,904
+2,804
+7% +$133K 1.01% 33
2019
Q3
$1.57M Buy
+42,100
New +$1.64M 0.69% 38

Other funds holding DXCM

Beck Bode LLC's DXCM Position: Q2 2026 in Review

Beck Bode LLC opened a new position in DexCom (DXCM) in Q2 2026: 3,579 shares worth $241K. The stake represents 0.04% of the portfolio and ranks #100 among its holdings. This is a return to the name: Beck Bode LLC previously reported a position in DXCM as recently as Q3 2020.

Beck Bode LLC first reported a position in DXCM in Q3 2019 and has held it in 6 quarters since. The position peaked at $11.6M in Q3 2020. 971 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Beck Bode LLC held 3,579 shares of DexCom worth $241K as of Q2 2026.
  • DexCom was a new Beck Bode LLC position in Q2 2026.
  • DexCom made up 0.04% of Beck Bode LLC's portfolio in Q2 2026, its #100 holding.
  • Beck Bode LLC first reported a position in DexCom in Q3 2019 and has held it in 6 quarters since.
  • Beck Bode LLC's DexCom position peaked at $11.6M in Q3 2020.
  • 971 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Beck Bode LLC's 13F filing for Q2 2026, filed 13 Aug 2026.